Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes New Brand Ambassador to Achieve Crown Ambassador Elite Rank

SAN DIEGO, Sept. 20, 2018 — Medical Marijuana, Inc. (OTC:MJNA), announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is recognizing its newest Brand Ambassador to reach the company’s Crown Ambassador Elite rank.

Valerie Aloisio has achieved the rank of Crown Ambassador Elite, which requires achieving a minimum of $1 million in monthly sales. She regularly attends national and regional Kannaway® events, participates in and hosts weekly webinars, networks with her fellow Brand Ambassadors, and educates herself constantly about cannabidiol (CBD).

“The Kannaway experience (the products and the people) has changed my life forever and has provided me with a platform to create a legacy that will be passed on for generations to come,” said Kannaway® Brand Ambassador Valerie Aloisio.

“We are very proud of Valerie’s achievement,” said Kannaway® Chief Executive Officer Blake Schroeder. “Her unwavering dedication to our company mission sets a great example and we look forward to supporting her journey as she continues to grow.”

About Kannaway, LLC

Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]